Evaluating the predictive power of circulating tumor cells for the prognosis of transarterial chemoembolization treatment on patients with advanced hepatocellular carcinoma

Explore the predictive power of Circulating Tumor Cells (CTCs) for evaluating the prognosis of transarterial chemoembolization (TACE) treatment on advanced hepatocellular carcinoma (HCC) patients, and use it to construct a prediction model. We retrospectively analyzed 43 patients with Barcelona Clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jun, Chen, Wei, Wu, Xiaoxia, Zhou, Yan, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793346/
https://www.ncbi.nlm.nih.gov/pubmed/33429769
http://dx.doi.org/10.1097/MD.0000000000024060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793346/
https://www.ncbi.nlm.nih.gov/pubmed/33429769
http://dx.doi.org/10.1097/MD.0000000000024060

Ejemplares similares